Preliminary findings from phase II portion of U.S. phase II/III trial of Kevzara in COVID-19 April 27, 2020
Polyneuron receives European clearances for phase I/IIa study of PN-1007 in anti-MAG neuropathy April 27, 2020
SAGE-324 generally well tolerated in essential tremor patients, phase II study planned April 27, 2020